Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis

Atopic Dermatitis

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

JAMA Dermatol.

Simpson EL, Guttman-Yassky E, Margolis DJ, Feldman SR, Qureshi A, Hata T, Mastey V, Wei W, Eckert L, Chao J, Arnold RJG, Yu T, Vekeman F, Suárez-Fariñas M, Gadkari A

doi: 10.1001/jamadermatol.2018.

Atopic Dermatitis

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

JAMA Dermatol.

Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP Jr

doi: 10.1001/jamadermatol.

Atopic DermatitisPsoriasis

Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults

Br J Dermatol.

Egeberg A, Griffiths CEM, Williams HC, Andersen YMF, Thyssen JP

doi: 10.1111/bjd.18622.

Atopic Dermatitis

The Patient-reported Disease Burden in Adults with Atopic Dermatitis: A Cross-sectional Study in Europe and Canada

J Eur Acad Dermatol Venereol.

de Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S, Girolomoni G, Papp K, Pink AE, Saba G, Werfel T, Eckert L

doi: 10.1111/jdv.16003.

Atopic Dermatitis

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

JAMA Dermatol.

Thorsteinsdottir S, Stokholm J, Thyssen JP, Nørgaard S, Thorsen J, Chawes BL, Bønnelykke K, Waage J, Bisgaard H

doi: 10.1001/jamadermatol.

Psoriasis

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL)

J Eur Acad Dermatol Venereol.

Seneschal J, Lacour JP, Bewley A, Faurby M, Paul C, Pellacani G, De Simone C, Horne L, Sohrt A, Augustin M, Hammond E, Reich K

doi: 10.1111/jdv.16568.

Atopic Dermatitis

Validation of five patient-reported outcomes for atopic dermatitis severity in adults

Br J Dermatol.

Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Fuxench ZC, Simpson EL

doi: 10.1111/bjd.18002.

Atopic Dermatitis

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

J Eur Acad Dermatol Venereol.

Maksimovic N, Zaric M, Reljic V, Nikolic M, Gazibara T

doi: 10.1111/jdv.15939.

RECOMMENDED

Atopic Dermatitis

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from 2 phase III trials

Br J Dermatol.

Silverberg JI, Simpson EL, Ardeleanu M, Thaçi D, Barbarot S, Bagel J, Chen Z, Eckert L, Chao J, Korotzer A, Rizova E, Rossi AB, Lu Y, Graham NMH, Hultsch T, Pirozzi G, Akinlade B

doi: 10.1111/bjd.17791.

Related content

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis

Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults

The Patient-reported Disease Burden in Adults with Atopic Dermatitis: A Cross-sectional Study in Europe and Canada

Genetic, Clinical, and Environmental Factors Associated With Persistent Atopic Dermatitis in Childhood

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL)

Validation of five patient-reported outcomes for atopic dermatitis severity in adults

Factors associated with improvement of quality of life among parents of children with atopic dermatitis: one-year prospective cohort study

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from 2 phase III trials